social-media-550766_640

Pharmafocus wants to hear from you!

pharmafile | July 17, 2017 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical 

We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new feature that focuses on you, the reader. Many of you work on the front lines of pharma and life sciences, affected by the issues that we report on every day.

Your insight is invaluable, and we want to hear your experiences and viewpoints on the latest developments and trends as they emerge.

Disagree with the latest drug approval decision? Maybe you, your family, or a patient are affected? Excited about the prospect of a promising set of new research findings? Or even want to discuss a topic as a feature in our regular ‘Opinion’ column? Whether it’s a throwaway observation or extended commentary, we want to hear what you have to say.

Advertisement

Get in touch with us at editorial@pharmafile.com or direct message us on Twitter and share your comments and thoughts – the best could even make it into the upcoming issue.

Related Content

Pharma sees climate disruption as growing supply-chain risk

Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact

In the decade to 2025, AI use in vaccine development has increased markedly but is …

Novogenia breaks ground on personalised healthcare campus

Novogenia AG has broken ground on a new headquarters and laboratory campus in Hallwang, Austria, …

The Gateway to Local Adoption Series

Latest content